A recent study conducted by researchers at Boston Medical Center has revealed that cannabis users may face a significantly higher risk of developing type 2 diabetes—nearly four times greater than non-users. Analyzing electronic health records from over 4 million adults across the United States and Europe, the research highlighted the potential metabolic health implications of increasing cannabis usage, which has risen globally, with approximately 219 million adults reporting use in 2021.
The study, which monitored participants for five years, identified nearly 97,000 individuals with cannabis-related diagnoses. The findings showed that 2.2% of cannabis users developed diabetes compared to just 0.6% of non-users. Factors such as insulin resistance and unhealthy eating habits, potentially exacerbated by the phenomenon known as the “munchies,” were suggested as contributors to this increased risk.
Lead researcher Dr. Ibrahim Kamel noted that cannabis may stimulate the endocannabinoid system, leading to fat accumulation and insulin resistance. While the study primarily focused on a healthy population devoid of common diabetes risk factors, it indicated that even relatively healthy adults could be at risk.
Experts suggest that lifestyle modifications could mitigate these risks, although further research is necessary to explore protective measures effectively. Dr. Chad Larson, not involved in the study, emphasized the importance of waist circumference as an early indicator of metabolic health and recommended strategies such as protein intake at dinner and regular exercise.
While the findings raise concerns regarding cannabis use and metabolic health, more comprehensive research is needed to fully understand the mechanisms at play and the implications for public health.